ABSTRACT
A key driver that leads to age-associated decline and chronic disease is mitochondrial dysfunction. Our prior work revealed strong community interest in the concept of mitochondrial fitness that led to development of a video based science communication intervention to prompt behavior change in adults aged 50+.
Aim To conduct formative and summative evaluations of MitoFit, an instructional, biologically based communication intervention aimed at improving physical activity (PA) in older adults, aged 50+.
Methods Phase 1 formative evaluation- Community-dwelling older adults (N=101), rated the acceptability, appropriateness and helpfulness of our MitoFit video series, titled, “How to Slow Down Aging Through Mitochondrial Fitness.” (≥ 4 out of five on a Likert-scale survey). Phase II summative evaluation- A subgroup of phase I participants (N=19) participated in a 1-month MitoFit intervention prototype to evaluate intervention and data collection feasibility (≥ 70% completion).
Results Phase I: Participants (mean age: 67.8 [SD 8.9]; 75% female) rated the MitoFit videos as acceptable (agree: 97%-100%), appropriate (agree: 100%) and helpful (agree: 95%-100%) to support adaptation and continued work on our novel approach. Phase II: Participants (mean age: 71.4 [SD 7.9]; 72% female) demonstrated MitoFit competencies (obtaining pulse, calculating maximum and zone 2 heart rate, demonstration of exercises). At one-month post-instruction, 13 participants (68.4%) had completed a self-initiated daily walking/exercise plan and submitted a daily activity log. Feasibility scores ranged from 89.4% to 94.7%. Fifteen participants (78.9%) stated an intention to continue the MitoFit intervention.
Conclusion MitoFit was enthusiastically embraced, and is a cost-effective, scalable, and efficacious intervention to advance with community-dwelling older adults.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by a Vanderbilt Seeding Success Faculty Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the institutional review board of Vanderbilt University Medical Center (IRB #230300).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Brandon.Grubbs{at}mtsu.edu, mary.dietrich{at}vanderbilt.edu, Jeffrey.t.boon{at}vanderbilt.edu, john{at}peer-tree.com, Kelly.knickerbocker{at}vanderbilt.edu, maulik.r.patel{at}vanderbilt.edu
*The authors of this publication have no disclosures or conflicts of interest to report. The authors and university did not received payments or services from any third parties for all aspects of the study.
**The study was funded by a Vanderbilt University Seeding Success Faculty Award.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
